GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) » Definitions » Shiller PE Ratio

Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Shiller PE Ratio : 25.77 (As of May. 13, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Tibet Rhodiola Pharmaceutical Holding Co Shiller PE Ratio?

As of today (2025-05-13), Tibet Rhodiola Pharmaceutical Holding Co's current share price is ¥36.08. Tibet Rhodiola Pharmaceutical Holding Co's E10 for the quarter that ended in Mar. 2025 was ¥1.40. Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio for today is 25.77.

The historical rank and industry rank for Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio or its related term are showing as below:

SHSE:600211' s Shiller PE Ratio Range Over the Past 10 Years
Min: 25.36   Med: 53.86   Max: 2417.58
Current: 25.77

During the past years, Tibet Rhodiola Pharmaceutical Holding Co's highest Shiller PE Ratio was 2417.58. The lowest was 25.36. And the median was 53.86.

SHSE:600211's Shiller PE Ratio is ranked worse than
53.14% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.6 vs SHSE:600211: 25.77

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Tibet Rhodiola Pharmaceutical Holding Co's adjusted earnings per share data for the three months ended in Mar. 2025 was ¥0.840. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥1.40 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tibet Rhodiola Pharmaceutical Holding Co Shiller PE Ratio Historical Data

The historical data trend for Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Rhodiola Pharmaceutical Holding Co Shiller PE Ratio Chart

Tibet Rhodiola Pharmaceutical Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.43 63.10 36.68 37.83 28.03

Tibet Rhodiola Pharmaceutical Holding Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.13 27.60 32.64 28.03 27.14

Competitive Comparison of Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio falls into.


;
;

Tibet Rhodiola Pharmaceutical Holding Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=36.08/1.40
=25.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tibet Rhodiola Pharmaceutical Holding Co's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Tibet Rhodiola Pharmaceutical Holding Co's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.84/115.1156*115.1156
=0.840

Current CPI (Mar. 2025) = 115.1156.

Tibet Rhodiola Pharmaceutical Holding Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.061 99.500 0.071
201509 0.148 100.500 0.170
201512 0.104 100.600 0.119
201603 0.076 102.200 0.086
201606 0.155 101.400 0.176
201609 0.214 102.400 0.241
201612 0.302 102.600 0.339
201703 0.203 103.200 0.226
201706 0.000 103.100 0.000
201709 0.236 104.100 0.261
201712 0.300 104.500 0.330
201803 0.209 105.300 0.228
201806 0.187 104.900 0.205
201809 0.308 106.600 0.333
201812 -0.048 106.500 -0.052
201903 0.214 107.700 0.229
201906 0.265 107.700 0.283
201909 0.354 109.800 0.371
201912 0.308 111.200 0.319
202003 0.562 112.300 0.576
202006 0.285 110.400 0.297
202009 0.308 111.700 0.317
202012 0.146 111.500 0.151
202103 0.485 112.662 0.496
202106 0.438 111.769 0.451
202109 0.377 112.215 0.387
202112 -0.654 113.108 -0.666
202203 0.538 114.335 0.542
202206 0.277 114.558 0.278
202209 0.562 115.339 0.561
202212 -0.231 115.116 -0.231
202303 0.938 115.116 0.938
202306 0.912 114.558 0.916
202309 0.800 115.339 0.798
202312 -0.170 114.781 -0.170
202403 0.970 115.227 0.969
202406 0.960 114.781 0.963
202409 0.530 115.785 0.527
202412 0.800 114.893 0.802
202503 0.840 115.116 0.840

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tibet Rhodiola Pharmaceutical Holding Co  (SHSE:600211) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Tibet Rhodiola Pharmaceutical Holding Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Tibet Rhodiola Pharmaceutical Holding Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tibet Rhodiola Pharmaceutical Holding Co Business Description

Traded in Other Exchanges
N/A
Address
No. 93, Beijing Middle Road, Tibet Autonomous Region, Lhasa, CHN, 610023
Tibet Rhodiola Pharmaceutical Holding Co is a Chinese company producing biological products and traditional Tibetan medicines.
Executives
Wang Bao Ming senior management
Peng Hui Director
Cao Shu Zhen senior management
Si Qin Director
Ren Bei Chen Supervisors
Liu De Gong Supervisors
Gao Zi Li senior management
Zhou Ming De senior management
Chen Li Ye senior management
Lin Ben Director
Chen Da Bin Director

Tibet Rhodiola Pharmaceutical Holding Co Headlines

No Headlines